Aldehyde dehydrogenase 1 family member A1 mRNA (ALDH1A1 mRNA)

Aldehyde dehydrogenase 1 family member A1 (ALDH1A1) mRNA is the transcript responsible for the production of the ALDH1A1 enzyme, a critical component in the metabolic oxidation of aldehydes and the synthesis of retinoic acid (NCBI Gene ID: 216). In clinical oncology, this mRNA is a significant therapeutic target because its overexpression is a hallmark of cancer stem cells (CSCs), which are responsible for tumor initiation, progression, and resistance to conventional chemotherapy (PubMed: 28415661). By targeting the mRNA directly through RNA interference (RNAi) or antisense oligonucleotides (ASOs), researchers aim to deplete the ALDH1A1 protein pool, thereby sensitizing cancer cells to treatment and inhibiting the self-renewal of CSCs (PubMed: 25633145). Beyond its role in cancer, ALDH1A1 mRNA levels are linked to metabolic regulation in obesity and the survival of dopaminergic neurons in Parkinson's disease (UniProt: P00352). Therapeutic strategies focusing on this mRNA transcript represent a precision medicine approach to modulating complex metabolic pathways that are often hijacked in disease states. Current research is focused on improving the delivery and specificity of these RNA-targeted agents to minimize off-target effects on other ALDH isoforms.

Other names

ALDH1 mRNAALDH11 mRNAALDC mRNAAldehyde dehydrogenase, cytosolic mRNAPQRR mRNA

RNA interference (RNAi) or antisense-mediated degradation of the transcript to prevent translation of the ALDH1A1 enzyme, thereby reducing its intracellular activity.